Home » Blog » Physicians saying, “Whoa, to the CMS horse race”!

Physicians saying, “Whoa, to the CMS horse race”!


IP Blog | Dave Melin | July 17, 2016

BioBlog Weekly oncologyThis week’s BioBlog presents a spectrum of articles from CMS and ASCO announcements, some politics, advertising expenditures in the cancer industry as well as promising studies for those battling cancer.

CMS could delay MACRA start date, Slavitt suggests

In this article from Fierce Healthcare, Andy Slavitt, Acting Administrator of the Centers for Medicare & Medicaid Services shared in his testimony, that CMS received 3,875 comments on the proposed rule to implement MACRA. Numerous groups representing physicians asked for more time for doctors to prepare for the changes to the Medicare payment system, as well as greater simplicity.

Political Activities May Need Policy Update as Fall Elections Loom

This article, Reprinted from REPORT ON MEDICARE COMPLIANCE, explores the three general areas of political activity and the possibility that they require monitoring by compliance.

CMS Releases CY 2017 Medicare Proposed Payment Regulations

CMS estimates that under the proposed policies in the MPFS reimbursement for hematology and oncology services will increase by 2 percent.

ASCO Announces the Fourteen Practices Participating in the 2016 Quality Training Program

This program, which is aimed at training oncology providers to enhance their quality of care, shares the fourteen practices which will be participating in the program.

Tennessee Oncology and Flatiron Health Partner to Advance the Development of Value-Based Care Products and Services

Tennessee Oncology and Flatiron Health will focus on leveraging Flatiron’s software and services to enable the development of new value-based care solutions, with a shared commitment to investing heavily in the future of oncology payment reform and technology to improve quality and cost.

Senators Introduce Bill to Revise Electronic Health Record Program

The bill would eliminate the program’s stipulation that doctors and hospitals meet all the program’s requirements or face Medicare payment cuts.

GE Aims for $1 Billion Cell Therapy ‘Tools’ Business with Swiss Deal

John Flannery, who leads GE Healthcare from its headquarters in Chalfont St Giles, England, stated in an interview, “We want to double down on life sciences, and especially so in the cell therapy business”.

Fasting-Like Diet Turns the Immune System Against Cancer

“This could be a very inexpensive way to make a wide range of cancer cells more vulnerable to an attack by the immune cells while also making the cancer more sensitive to the chemotherapy.” – Valter Longo, professor and director of the USC Longevity Institute at the USC Leonard Davis School of Gerontology.

Advertising by U.S. Cancer Centers Soars Over the Past Decade, New Analysis shows

Researchers at Indiana University School of Medicine and the University of Pittsburgh School of Medicine and Graduate School of Public Health reported that 890 cancer centers spent $173 million for advertising in 2014, and just 20 centers accounted for 86 percent of the spending.

Why Breast Cancer Survivors Should Exercise

This article discusses the findings that were published July 8 in Psycho-Oncology, indicating that exercise may help in reducing perceived memory loss, also known as ‘chemo brain’.

Want more health care landscape updates and insights? Follow us on Twitter @innovpartners


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *